Obesity &Amp; Overweight
50
14
25
13
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 50 trials
100.0%
+13.5% vs benchmark
4%
2 trials in Phase 3/4
8%
1 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (50)
Soup and Bread Recipe Impacts on Ingestive Behavior
Effects of Concurrent Aerobic and Resistance Training After Bariatric Surgery in Women: RCT
HealthyWE: Achieving a Healthy Weight and Reducing Pain
Postoperative Opioid Consumption in Gastric Sleeve Surgery
This is an Open-label, Non-randomized Study to Assess the Pharmacokinetics (PK) of VCT220 in Healthy Volunteers When Administered With Rifampin or Itraconazole
A Drug Drug Interaction Study to Evaluate the Effect of VCT220 on the Pharmacokinetics of Repaglinide, Rosuvastatin, and Digoxin in Healthy, Overweight, and Obese Subjects
Effect of a Dietary Supplement on Hormones Involved in Appetite Regulation in Overweight and Obese Adults
Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)
Sanctuary Farm Prescription in Adolescents
3D-Printed Artificial Airway Fixation Device for Obese Patients
Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer
Effects of Three Dietary Strategies on Body Composition and Metabolic Health in Adults With Overweight or Obesity
Effects of Grape Consumption on the Immune-Gut Axis in Obesity
Training App for Inhibitory Control Towards Food
A Prospective Randomnised Controlled Trial Comparing Overall Patient Compliance in a Bariatric Surgical Pathway Using the Standard Versus a More Intensified and Interactive Version of the "Get Ready" Smartphone Application.
Validation of a Score for Supplementation Needs of Vitamins, Micronutrients and Proteins After Bariatric Surgery
The Impact of Probiotics on Bariatric Treatment Outcomes
UBT251 Injection Phase II Clinical Study (CKD)
Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity
An Evaluation of "Growing Healthy Places: Mississauga"